IModMix allows the analysis and integration of multi-omics data types. If metabolomics abundance and proteomics or transcriptomics expression data from the same samples are available, they can be correlated (integrated) using iModMix. To ensure optimal performance and accurate results, please follow these guidelines to prepare and upload your data:
Example of abundance/expression data that can be uploaded in the ‘Metabolomics Abundance Data’ and ‘Proteomics/Genomics Expression Data’ tabs.
If available, metadata file is optional but recommended for optimal tool performance.
Prepare a separate metadata file containing the experimental design and sample labels. It should have the following columns:
Example metadata data that can be uploaded in the ‘Metadata’ tab.
If available, annotation files are optional but recommended for optimal tool performance.
Metabolomics Annotation data should have the following labeled columns:
Proteomics or Genomics Data: It should have the following columns:
Example annotation data that can be uploaded in the ‘Metabolomics Annotation Data’ and ‘Proteomics/Genomics Annotation data’ tabs.
To ensure your data is ready for analysis, please follow these guidelines:
Two case studies are available to help you get started with iModMix. You can use this data to run the application and explore its features.
Case Study 1. Clear cell renal cell carcinoma (ccRCC, RC20) Dataset with Identified Metabolites We used 76 clear cell renal cell carcinoma (ccRCC) samples, 24 normal and 52 tumor (Golkaram et al. 2022; Tang et al. 2023; Benedetti et al. 2023) as a case study.
Applying iModMix identified 751 gene modules and 34 metabolite modules. Differential expression analysis of the modules through t-test confirmed changes in metabolite abundance between highlighting reduced levels of gamma-glutamyltyrosine (module ME#BA3241, P-value: 0.0003), creatinine/C00791 (module ME#C06162 P-value: 4.2681E-15), xanthosine/C01762 (module ME#66628D P-value: 0.0015), docosahexaenoate (DHA; 22:6n3)/C06429 (module ME#904A67 P-value: 4.6906E-12), and 1-methyladenosine/C02494 (module ME#E1C62F P-value: 8.1847E-14) in tumors compared to normal tissue. Conversely, metabolites with increased abundance in tumors compared to normal tissues included proline/C00148, glutamine/C00064 (module ME#6C856F, P-value: 0.006), maltose/C00208 and 1-methylnicotinamide/C02918 (module ME#904A67 P-value: 4.6906E-12).
Case Study 2. Lung Adenocarcinoma (LUAD) Dataset with Unidentified Metabolites Matched proteomics and metabolomics dataset was generated using two mouse models for lung adenocarcinoma (LUAD) (10 wild type, 10 knockout).
Applying iModMix generated 412 gene modules, and 287 metabolite modules. Strong correlations were observed between these modules, with correlations as high as 0.93. The correlations observed between variables in the 2 and 3 correlated pairs are notably high, with numerous correlations between proteins and both identified and unidentified metabolites exceeding 0.9. These strong correlations offer valuable insights into the unidentified metabolites, providing crucial information about their potential relationships and helping to elucidate their behavior.